Navigation Links
Olympus Introduces the World's First and Only Monopolar, Disposable Tonsil Adenoid Debrider (DTAD)
Date:9/11/2012

CENTER VALLEY, Pa. and SOUTHBOROUGH, Mass., Sept. 11, 2012 /PRNewswire/ -- Olympus, a precision technology leader in designing and delivering innovative solutions in Medical and Surgical Products, among other core businesses, announced their FDA-cleared DTAD (Disposable Tonsil Adenoid Debrider) at this year's AAO-HNSF annual meeting.

The Olympus DTAD is the world's first and only disposable tonsil adenoid debrider that combines monopolar energy and distal suction with a malleable shaver blade. Using proprietary FLEXBLADE Technology, DTAD's malleable shaver blade is designed to provide optimum access to adenoid and tonsil anatomy in a singular device without requiring the exchange of blade parts or use of tools during a procedure. DTAD is also the world's only battery-powered debrider, making it easy to set up and easy to use without any additional capital investment in a console or other equipment.

"By combining monopolar energy with a malleable shaver blade, Olympus' unique DTAD allows the surgeon to cut and coagulate with a single device, reducing the need to exchange instruments," says Sandra Tilden, Vice President of Marketing for Olympus' Surgical Business. "DTAD also plugs into any standard monopolar generator so our customers can realize capital efficiencies by not having to purchase a new console."

As a battery-powered device that also does not require irrigation or a dedicated console, DTAD makes faster setup time possible through "Plug and Play" implementation. In addition, distal suction allows the shaver blade to be used as a suction device for blood and fluid leading to better visualization of the surgical site.

"Our mission is to design, develop, and manufacture world-class, innovative solutions like DTAD as we strive to help make surgery safer, easier and more efficient for our customers," says Georg Schloer, President of Olympus Surgical Technologies America which is a manufacturing arm of Olympus. "Olympus is committed to helping surgeons and physicians perform advanced procedures to elevate the standards of patient care and deliver better treatment, while improving outcomes and enhancing the quality of life."

The Olympus DTAD is scheduled to be available in the U.S in the fourth quarter of 2012. 

About Olympus
Olympus is a precision technology leader, designing and delivering innovative solutions in its core business areas: Medical and Surgical Products, Life Science Imaging Systems, Industrial Measurement and Imaging Instruments and Cameras and Audio Products.

Olympus works collaboratively with its customers and affiliates worldwide to leverage R&D investment in precision technology and manufacturing processes across diverse business lines. These include:

  • Gastrointestinal endoscopes, accessories, and minimally invasive surgical products;
  • Advanced research, clinical and educational microscopes and research and educational digital imaging systems;
  • Industrial research, engineering, test, inspection and measuring instruments; and
  • Digital cameras and voice recorders.

Olympus serves the healthcare field with integrated product solutions and financial, educational and consulting services that help customers to efficiently, reliably and more easily achieve exceptional results. Olympus develops breakthrough technologies with revolutionary product design and functionality for the consumer and professional photography markets, and also is the leader in gastrointestinal endoscopy and clinical and educational microscopes.  For more information, visit www.olympusamerica.com.


'/>"/>
SOURCE Olympus America Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. IBA Molecular Introduces Centers for Innovation
2. Kalidex Introduces Novel Fluoroquinolone, KPI-10, at the 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)
3. Zarbees Introduces a New Extra Strength Line of Natural Cough Products for Adults and Children 12+ in Time for Cough and Cold Season
4. Cool Containers Introduces a Non-Dry Ice Active Container for Frozen Shipments
5. Indegene Introduces TrialPedia 2.0 with Advantage Insights, Making It the Most Comprehensive Clinical Trial Analytics and Decision Support Platform for the Pharma Industry
6. FUJIFILM Introduces U.S.As First 24x30cm Wireless Detector At AHRA
7. FUJIFILM Introduces Flexible DR Room Offering
8. TI introduces the industrys first weigh scale and body composition analog front end
9. Vivant Skin Care Introduces 8% Mandelic Acid 3-in-1 Serum for Those New to Advanced Skin Care
10. Dr. Milton Owens, Well Known Bariatric Surgeon, Introduces Innovative "Inverted Corner Gastric Sleeve technique," An advanced technique that makes weight loss surgery even safer
11. Misonix Attends International Meeting On Advanced Spine Techniques (IMAST) - Introduces New Product
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... -- Nevro Corp. (NYSE: NVRO), a global medical device company ... chronic pain, today reported financial results for the three months ... 2016 Accomplishment & Highlights: Achieved revenue of ... 228% as reported, over the prior year U.S. ... over the prior year International revenue of ...
(Date:2/23/2017)... REDWOOD CITY, Calif. , Feb. 23, 2017 ... specialty pharmaceutical company focused on the development and ... moderate-to-severe acute pain, announced that it will release ... close on Thursday, March 2nd, 2017. AcelRx management ... p.m. Eastern Time (1:30 p.m. Pacific Time) on ...
(Date:2/23/2017)... , Feb 23, 2017 ... Research and Markets has announced the ... Industry Forecast to 2025" report to their offering. ... of around 1.8% over the next decade to reach approximately $12.8 billion ... estimates and forecasts for all the given segments on global as well ...
Breaking Medicine Technology:
(Date:2/23/2017)... ... February 23, 2017 , ... Curemark, LLC announced today ... efficacy of CM-AT in children aged 3-8 with Autism, is now enrolling at three ... enrolling children across the United States. , “There are currently no approved drugs ...
(Date:2/22/2017)... ... February 22, 2017 , ... When it came ... contact center in Georgia, PENETRON Specialty Products (PSP) provided the solution. January’s grand ... recently invested $51 million to purchase and renovate the 185,000 square-foot office complex, ...
(Date:2/22/2017)... ... 2017 , ... The Waismann Method® is providing a faster, safer, ... fallen victim to America’s opioid epidemic. Now, opiate dependent individuals can be treated in ... from the shame, stigma, and harmful labeling believed to prevent many of ...
(Date:2/22/2017)... N.J. (PRWEB) , ... February 22, 2017 , ... ... a one-size-fits-all approach, leads to fewer trips the emergency room, fewer hospital admissions, ... The American Journal of Managed Care® (AJMC®) finds. The study can be found ...
(Date:2/22/2017)... ... , ... Doctors on Liens is continuing its steady expansion of medical specialties ... at North Valley Eye Medical Group in Mission Hills . Eye injuries and ... injury cases. These injuries have a major impact on the quality of life ...
Breaking Medicine News(10 mins):